USC/Norris Comprehensive Cancer Center, Los Angeles
University of California, Irvine (UCI) Health - UC Irvine Medical Center, Orange
Local Institution - 0428, San Francisco

Prebieha náborFáza 2/3

Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT07221149

Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma

UCLA Health, Los Angeles

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 9. 2026 · NCT07700979

Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

UCLA Hematology/Oncology - Atascadero, Atascadero
UCLA Hematology/Oncology - Burbank, Burbank
UCLA Hematology/Oncology - Encino, Encino
a 5 ďalších

Prebieha náborFáza 2/3

Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07392892

IKS014 in Advanced Solid Tumors That Express HER2

Hoag Memorial Hospital Presbyterian, Newport Beach

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT05872295

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Precision NextGen Oncology, Beverly Hills
OPN Healthcare, Inc, Glendale
University of Southern California, Los Angeles

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT06047379

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

Research Site, Los Angeles
Research Site, Santa Rosa

Prebieha náborFáza 2

Vek 18 až 130 · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT05489211

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

City of Hope, Duarte
University of California, Los Angeles (UCLA), Santa Monica
Stanford University Medical Center, Stanford

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07114601

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Hoag Memorial Hospital Presbyterian, Newport Beach
Stanford University Medical Center, Stanford

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07213791

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

UC IRVINE Health, Orange
UC Davis Comprehensive Cancer Center, Sacramento
Stanford Cancer Institute, Stanford

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT06128551

Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients

Stanford Cancer Center, Palo Alto

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 21. 9. 2026 · NCT05274048

Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.

Helios CR Inc./RadNet, Cerritos
City of Hope National Cancer Center, Duarte
Hoag Memorial Hospital, Irvine
a 2 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 9. 2026 · NCT07217704

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

City of Hope, Duarte
START - Los Angeles, Los Angeles
Cedars Sinai, Los Angeles
a 1 ďalších

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 10. 9. 2026 · NCT06293898

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

Research Site, Duarte
Research Site, Fountain Valley
Research Site, Fullerton
a 5 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT07431281

A Phase 1/1b Study of IAM1363 in HER2 Cancers

UCSD Moores Cancer Center, La Jolla
USC Norris Comprehensive Cancer Center, Los Angeles

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT06253871

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

University of California San Francisco, San Francisco

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT07070232

Ph II Intraperitoneal Paclitaxel + System Therapy in GI Ca w/Peritoneal Carcinomatosis (STOPGAP-B)

Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 31. 8. 2026 · NCT07795749

Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA

UCLA, Santa Monica

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 8. 2026 · NCT07070466

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

UC San Diego Moores Cancer Center, San Diego

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 27. 8. 2026 · NCT07227168

PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

City of Hope Medical Center, Duarte

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 26. 8. 2026 · NCT04329494

Patient-Derived Xenografts to Reduce Cancer Health Disparities

UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
University of California Davis Comprehensive Cancer Center, Sacramento

Prebieha náborObservačná štúdia

Vek 21 až 100 · Všetky pohlavia · Aktualizované 20. 8. 2026 · NCT04410302

Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers

University of California, San Francisco, San Francisco
John Muir Medical Center-Walnut Creek, Walnut Creek

Prebieha nábor

Vek 18 a viac · Všetky pohlavia · Aktualizované 14. 8. 2026 · NCT04221893

A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

ULCA, Los Angeles
UCSF, San Francisco

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 13. 8. 2026 · NCT07066657

A Study of MGC026 in Participants With Advanced Solid Tumors

The Angeles Clinic and Research Institute, Los Angeles

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 11. 8. 2026 · NCT06242470

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

City of Hope, Duarte
Los Angeles Cancer Network, Glendale
California Research Institute, Los Angeles
a 3 ďalších

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 7. 2026 · NCT04198766

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

UCSD, La Jolla
Sharp Healthcare, San Diego

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 7. 2026 · NCT03526835

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

Investigative Site #101, San Diego

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 7. 2026 · NCT06974110

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
University of California Davis Comprehensive Cancer Center, Sacramento
a 1 ďalších

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 7. 2026 · NCT05208762

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte
IP Address: City of Hope Investigational Drug Services(IDS), Duarte

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 7. 2026 · NCT06131840

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

City of Hope, Duarte

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 7. 2026 · NCT06657144

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

Chao Family Comprehensive Cancer Center, University of California Irvine, Orange

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 14. 7. 2026 · NCT06580002

A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer

City of Hope Nat Medical Ctr, Duarte

Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov

Vek 18 a viac · Všetky pohlavia · Aktualizované 7. 7. 2026 · NCT07224750

Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.